Report error Found 495 Enz. Inhib. hit(s) with Target = 'Receptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255]'
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 3.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 4.20nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 4.40nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 4.80nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 4.80nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 4.90nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 5.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 5.70nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 5.80nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 6.40nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.10nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.30nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.5nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 7.90nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.20nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.20nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.30nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.40nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.5nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.70nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 8.90nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 9.30nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 9.40nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 9.60nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 9.80nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.1nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.1nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.2nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.3nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.4nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.8nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.9nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 10.9nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.2nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.3nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.5nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.7nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.8nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 11.9nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2 [676-775,'YVMA',776-1255](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent
Affinity DataIC50: 12.1nMAssay Description:This synthesized DNA fragment was subsequently cloned into the baculovirus transfer vector, pAcSG2, between the NcoI and NotI sites. The resulting pl...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)